Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease
Farida Dakterzada(Hospital Universitari de Santa Maria), Gerard Piñol‐Ripoll(Hospital Clínico Universitario Lozano Blesa), Raquel Huerto(Hospital Universitari de Santa Maria), Joaquím Sol(Universitat de Lleida), Mariona Jové(Universitat de Lleida), Reinald Pamplona(Universitat de Lleida), Anna Carnes(Hospital Universitari de Santa Maria)
Cited by 20
Related Papers
Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown
|European Journal of Neurology|2020|215
Depression and Apathy After Transient Ischemic Attack or Minor Stroke: Prevalence, Evolution and Predictors
|Scientific Reports|2019|69
Severe infantile-onset cardiomyopathy associated with a homozygous deletion in desmin
|Neuromuscular Disorders|2009|67
COVID-19 severity is related to poor executive function in people with post-COVID conditions
|Journal of Neurology|2023|56
Prevalence of obstructive sleep apnea in Alzheimer’s disease patients
|Journal of Neurology|2019|51